Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasis

Clinical trial NCT00524849 · COMPLETED

Trial details

NCT number: NCT00524849
Sponsor: Fudan University
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Metastatic Breast Cancer Bone Metastases

Start date: 2006-11-01
Primary completion: 2008-08-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.